Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

Matthias Staufenbiel

Matthias Staufenbiel publishes mostly in Physiology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Alzheimer's disease research and treatments, Prion Diseases and Protein Misfolding and Cholinesterase and Neurodegenerative Diseases.

OpenAlex
World rank
#64,859
of 7,710,434 ranked researchers
Rank in Switzerland
#1,390
of 80,918
Works
296
Citations
35k
Citations per work
116.6
h-index
95
i10-index 200Top 0.4% in Physiology (Medicine)
Matthias Staufenbiel

What does Matthias Staufenbiel research?

Matthias Staufenbiel's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (20%), Neuroscience (12%).

Health Sciences: 112 works · 37.8% of their workMedicine: 112 works · 37.8% of their workPhysiology: 85 works · 28.8% of their workPharmacology: 15 works · 5.2% of their workNeurology: 11 works · 3.8% of their workLife Sciences: 97 works · 32.8% of their workBiochemistry, Genetics and Molecular Biology: 60 works · 20.4% of their workMolecular Biology: 60 works · 20.4% of their workNeuroscience: 37 works · 12.4% of their workCellular and Molecular Neuroscience: 22 works · 7.6% of their workNeurology: 14 works · 4.8% of their workEverything else: 87 works · 29.4% of their workTHEIR WORKMatthiasStaufenbiel296works
Life Sciences33%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine11237.8%
    1. Biochemistry, Genetics and Molecular Biology6020.4%
    2. Neuroscience3712.4%
  3. Everything else8729.4%
  1. 1Physiology29% of their works
  2. 2Molecular Biology20% of their works
  3. 3Cellular and Molecular Neuroscience8% of their works
  4. 4Pharmacology5% of their works
  5. 5Neurology5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Matthias Staufenbiel's research?

The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Neurodegenerative Diseases, Alzheimer's Disease, Molecular Basis and Prion Diseases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Neurodegeneration2763 topics
  2. Neuroinflammation2552 topics
  3. Amyloid Hypothesis2261 topic
  4. Tau Pathology2261 topic
  5. Neurodegenerative Diseases902 topics
  6. Alzheimer's Disease632 topics
  7. Molecular Basis471 topic
  8. Prion Diseases471 topic
  9. Acetylcholinesterase431 topic
  10. Cholinesterase Inhibitors431 topic
  11. Astrocytes291 topic
  12. Microglia291 topic
  13. Molecular Docking251 topic
  14. Virtual Screening251 topic
  15. Neurotransmission231 topic
  16. Synaptic Plasticity231 topic
  17. NR4A2211 topic
  18. Nurr1211 topic
  19. Dementia201 topic
  20. Mild Cognitive Impairment201 topic

Where does Matthias Staufenbiel work?

Matthias Staufenbiel's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does Matthias Staufenbiel have?

OpenAlex counts 296 works and 34,510 citations for Matthias Staufenbiel, an h-index of 95, ranking #64,859 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matthias Staufenbiel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.